GIC-backed Chinese pharma firm CStone seeks up to $282m in HK IPO

Chinese biopharmaceutical firm CStone Pharmaceuticals is looking to raise as much as HK$2.2 billion ($282 million) in its upcoming Hong Kong IPO next week at an expected HK$12.6 billion ($1.6 billion) market cap.